- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Sensitizing EGFR Mutations
Total 2622 results
-
Yuhan CorporationCompleted
-
AstraZenecaCompletedNon-small Cell Lung CancerVietnam, Turkey, Philippines, Thailand, Egypt, Singapore, India, Peru, Argentina, Chile, Colombia, Costa Rica, Dominican Republic, Kuwait, Mexico
-
AstraZenecaCompletedLocally Advanced or Metastatic EGFR T790M+ NSCLCCanada, Korea, Republic of, Taiwan
-
Rain Oncology IncTerminatedNSCLC Stage IIIB | NSCLC, Recurrent | NRG1 Fusion | EGFR Exon 20 Insertion Mutation | NSCLC, Stage IIIC | NSCLC, Stage IV | HER2-activating Mutation | ERBB FusionUnited States, Canada, Hong Kong
-
Revolution Medicines, Inc.SanofiCompletedSolid TumorUnited States, Korea, Republic of
-
Yonsei UniversityWithdrawnRecurrent/Advanced Gastric CancerKorea, Republic of
-
Boehringer IngelheimCompletedNon-squamous, Non-Small Cell Lung CancerUnited Kingdom
-
First Affiliated Hospital of Zhejiang UniversityEnrolling by invitationNon Small Cell Lung CancerChina
-
Royal Cornwall Hospitals TrustBiocartisCompletedPancreatic Adenocarcinoma | Lung CancerUnited Kingdom
-
Centre Hospitalier Universitaire de la RéunionCompletedSquamous Cell Lung CancerRéunion
-
Millennium Pharmaceuticals, Inc.Approved for marketing
-
ETOP IBCSG Partners FoundationSpanish Lung Cancer GroupCompletedLung CancerSpain, Ireland, United Kingdom, Switzerland, France, Germany, Greece, Italy
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.Active, not recruitingNon-small Cell Lung CancerChina
-
Spanish Lung Cancer GroupCompletedNon-Small Cell Lung CancerSpain, France, Italy
-
National Cancer Center, KoreaHoffmann-La RocheActive, not recruitingNSCLC Stage II | NSCLC, Stage IIIAKorea, Republic of
-
Sihuan Pharmaceutical Holdings Group Ltd.Covance; XuanZhu Pharma Co., Ltd.CompletedAdvanced Solid TumorsUnited States
-
Chul KimBristol-Myers Squibb; AstraZeneca; Walter Reed National Military Medical Center; Hackensack Meridian HealthActive, not recruitingNonsmall Cell Lung Cancer | EGFR Gene MutationUnited States
-
Central Hospital, Nancy, FranceInstitut de Cancérologie de LorraineEnrolling by invitationLung Cancer | Non Small Cell Lung Cancer | Lung Adenocarcinoma | KRAS Mutation-Related Tumors | EGFR Activating MutationFrance
-
Chonnam National University HospitalCompletedLung Neoplasms | EGFR Gene MutationsKorea, Republic of
-
Spectrum Pharmaceuticals, IncTerminated
-
PfizerTerminatedNon-Small Cell Lung CancerUnited States, Korea, Republic of, Australia, Japan
-
AstraZenecaiOMEDICO AG, Freiburg, GermanyCompletedCarcinoma, Non-Small-Cell LungGermany
-
Tianjin Medical University Cancer Institute and...Chia Tai Tianqing Pharmaceutical Group Co., Ltd.CompletedNon Small Cell Lung CancerChina
-
European Organisation for Research and Treatment...Active, not recruitingEGFR Mutation Positive Non Small Cell Lung CancerUnited Kingdom
-
Sun Yat-sen UniversityEnrolling by invitation
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)TerminatedRecurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | EGFR Activating MutationUnited States
-
AstraZenecaCompletedEGFR Mutation Positive Advanced Non Small Cell Lung CancerUnited States, Korea, Republic of, Taiwan, Australia
-
Hellenic Cooperative Oncology GroupCompletedNon Small Cell Lung Cancer | EGF-R Positive Non-Small Cell Lung Cancer | EGFR Gene Mutation
-
Shandong Cancer Hospital and InstituteChia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownNon Small Cell Lung CancerChina
-
PfizerCompletedSolid Tumor | Unspecified Adult Solid Tumor, Protocol SpecificUnited States, Australia, Canada, France, Spain
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)CompletedLung Non-Squamous Non-Small Cell Carcinoma | Stage IV Lung Non-Small Cell Cancer AJCC v7 | EGFR Exon 19 Deletion Mutation | EGFR NP_005219.2:p.L858RUnited States
-
Array Biopharma, now a wholly owned subsidiary...CompletedAdvanced Solid Tumors | Selected Solid TumorsUnited States, Germany, Canada, Spain, Netherlands, Singapore, Switzerland
-
Shanghai Cancer Hospital, ChinaUnknownLung Cancer Stage IV,EGFR-mutant,TKI,PD-L1,SBRTChina
-
Massachusetts General HospitalYale University; Genentech, Inc.; Stanford University; University of Maryland,...UnknownNon-small Cell Lung CancerUnited States
-
AstraZenecaCompletedNon-Small Cell Lung CancerRussian Federation
-
Royal Cornwall Hospitals TrustBiocartisCompletedAdenocarcinoma of LungUnited Kingdom
-
Cancer Institute and Hospital, Chinese Academy...UnknownNon Small Cell Lung Cancer | Stage III Non-small-cell Lung Cancer | EGFR Mutation-Related Tumors
-
Guangdong Association of Clinical TrialsPeking University First Hospital; Zhejiang Cancer Hospital; Peking University... and other collaboratorsUnknownNon-small Cell Lung CancerChina
-
Changi General HospitalCompleted
-
Astellas Pharma Global Development, Inc.CompletedNon-Small-Cell Lung Cancer (NSCLC) | Epidermal Growth Factor Receptor MutationsUnited States
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungGermany
-
Allist Pharmaceuticals, Inc.UnknownLocally Advanced or Metastatic EGFR Sensitising Mutation Positive Non-small Cell Lung CancerChina
-
Allist Pharmaceuticals, Inc.Unknown
-
Novartis PharmaceuticalsWithdrawn
-
National Cancer Institute (NCI)CompletedNon-Small-Cell Lung CarcinomaUnited States, Mexico, Bolivia, Peru, Venezuela
-
AstraZenecaMedpace, Inc.CompletedNon-small Cell Lung CancerUnited States, Canada
-
Astellas Pharma IncTerminatedNon-small Cell Lung CancerJapan, Korea, Republic of, Taiwan
-
Konkuk University Medical CenterHanmi Pharmaceutical Company LimitedCompletedNon Small Cell Lung CancerKorea, Republic of
-
Novartis PharmaceuticalsTerminatedAdvanced Non Small Cell Lung Cancer (NSCLC)France, Italy, Taiwan, Spain, Netherlands, Japan, Hong Kong, Korea, Republic of, Norway, United States, United Kingdom, Poland